Neurology

show blocks helper

Sort by Default

Display 15 Products per page

Extremity Replacement Implants

€4,473.08

This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets. Geographic segments covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.
December 21, 2020
Find out more
Respiratory Care: Noninvasive Ventilation and Airway Management Products

€4,473.08

Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

December 17, 2020
Find out more
Neuromodulation: Spinal Cord Stimulation Devices Market

€4,473.08

Despite the severe impact of the COVID-19 pandemic on elective surgeries, global sales of neuromodulation systems for the treatment of chronic, intractable pain—which include innovative implantable spinal cord stimulation (SCS) devices and associated products—is expected to increase at a healthy CAGR of approximately 8.6%, from nearly $3bn in 2019 to an estimated $4.5bn in 2024.
July 30, 2020
Find out more
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

€4,473.08

This comprehensive medical market and technology report provides an overview and in-depth market analysis of devices used in the treatment of peripheral vascular disease (PVD), including peripheral arterial disease (PAD) of the lower extremities; and deep vein thrombosis (DVT) and pulmonary embolism (PE).
May 28, 2020
Find out more
Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

€4,473.08

An overview of primary neurological diseases/disorders treated with vagus nerve stimulation (VNS) and deep brain stimulation (DBS), as well as overview of VNS and DBS neuromodulation technologies, markets, competitors, sales and forecasts. Markets covered include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets.
May 8, 2020
Find out more
Drug Delivery: Transdermal Devices

€4,473.08

This comprehensive medical market and technology report provides a comprehensive discussion of transdermal drug delivery technology for the treatment of cardiovascular disease (CVD), neurological disorders, hormone replacement therapy (HRT), pain management, and genitourinary disorder management. Markets covered by this analysis include the US, Japan, the five major EU markets (France,Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.
April 15, 2020
Find out more
Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

€4,473.08

Valued at approximately $1.1bn in 2017, the implantable Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS) Device Markets are two important and growing neuromodulation segments (outside of the largest, most dynamic $2.5bn segment, Spinal Cord Stimulation or SCS).
August 31, 2018
Find out more
Datamonitor Healthcare Parkinson’s Disease KOL Interviews

€564.08

Datamonitor Healthcare interviewed two neurologists, one based in Italy and the other in the US, to gauge their prescribing habits and views on current treatment options and challenges, late-stage clinical candidates and pricing and reimbursement considerations for Parkinson’s disease.
April 18, 2017
Find out more
Migraine KOL Interview

€564.08

We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic and chronic migraine.

April 12, 2017
Find out more
United Kingdom, Surgical Procedure Volumes

€4,567.25

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.
September 22, 2016
Find out more
France, Disease Incidence and Prevalence

€4,567.25

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

September 22, 2016
Find out more
U.S. Markets for Heart Valve Disorder Management Products

€4,473.08

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.
September 22, 2016
Find out more
U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

€3,531.38

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015
September 22, 2016
Find out more
U.S. Markets for Neurosurgical and Neurointerventional Products

€3,531.38

This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market.
September 22, 2016
Find out more
U.S. Neurostimulation Devices Market, June 2015

€4,943.93

An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.
September 22, 2016
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *